An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold.

Chem Biol Drug Des

Institute of Pharmaceutical Research, GLA University, Mathura, UP, India.

Published: March 2021

Pyrido[2,3-d]pyrimidine, a fused hetero-bicyclic nucleus containing pyridine and pyrimidine rings has attained the momentary attention in the sphere of multicomponent synthetic protocol and medicinal chemist. Pyrido[2,3-d]pyrimidine derived drugs have manifested diverse pharmacological activities, particularly, anti-inflammatory, cytotoxic, antimicrobial, phosphodiesterase inhibitors and cytokine inhibitors etc. The present review illustrates various modern synthetic strategies adopted, the structure-activity relationship (SAR) aspects and discloses the extensive crucial biological properties (anticancer, anti-infectious, anti-diabetics and CNS agents) of pyrido[2,3-d]pyrimidines.

Download full-text PDF

Source
http://dx.doi.org/10.1111/cbdd.13800DOI Listing

Publication Analysis

Top Keywords

overview synthetic
4
synthetic pharmaceutical
4
pharmaceutical prospective
4
prospective pyrido[23-d]pyrimidines
4
pyrido[23-d]pyrimidines scaffold
4
scaffold pyrido[23-d]pyrimidine
4
pyrido[23-d]pyrimidine fused
4
fused hetero-bicyclic
4
hetero-bicyclic nucleus
4
nucleus pyridine
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!